Supernus Pharmaceuticals
SUPN
#5037
Rank
C$2.48 B
Marketcap
C$42.63
Share price
1.78%
Change (1 day)
-33.80%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2026 (TTM): -C$51.25 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are C$0.86 Billion. In 2025 the company made an earning of -C$60.57 Million a decrease over its 2024 earnings that were of C$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$51.25 Million-15.39%
2025 -C$60.57 Million-152.66%
2024 C$0.11 B1446.62%
2023 C$7.43 M-92.36%
2022 C$97.26 M-29.8%
2021 C$0.13 B-49.79%
2020 C$0.27 B12.99%
2019 C$0.24 B7.58%
2018 C$0.22 B54.9%
2017 C$0.14 B84.25%
2016 C$79.54 M202.27%
2015 C$26.31 M-462.04%
2014 -C$7.27 Million-94%
2013 -C$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.85 B-51,828.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$10.35 B-20,044.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$49.87 B-96,171.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.25 B-31,411.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
-C$0.31 Billion 485.87%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
C$2.17 B-4,299.11%๐Ÿ‡บ๐Ÿ‡ธ USA